Company Statement: Celgene to acquire Pharmion for $2.9 billion in cash and stock
****************************************SUMMIT, N.J. & BOULDER, Colo.--(BUSINESS WIRE)--Nov. 19, 2007--Celgene Corporation (Nasdaq: CELG) and Pharmion Corporation (Nasdaq: PHRM) today jointly announced the signing of a definitive merger agreement pursuant to which Celgene has...To view the full article, register now.
Already a subscriber? Click here to view full article